LoginRegister

    Sun Pharma launches generic Glumetza tablets in US

    Written by Ruby Khatun Khatun   |  
    Sun Pharma launches generic Glumetza tablets in US

    New Delhi: Sun Pharmaceutical Industries to said one of its wholly-owned subsidiaries has launched generic metformin hydrochloride extended-release tablets, used for glycemic control, in the US market.


    The tablets have been launched in the strengths of 500 mg and 1000 mg, it said in a filing to BSE.


    The tablets are generic versions of Santarus Inc's Glumetza HCl extended-release tablets in the same strengths, it added.

    "The addressable market size is approximately USD 443 million for the 12 months ending April 2018, as per IQVIA," Sun Pharma said.

    The tablets are used to improve glycemic control in adults with type 2 diabetes.
    genericgeneric versionGlumetza HCl extended-release tabletsGlumetza tabletsglycemic controllaunchesmetformin hydrochloride extended-release tabletsSantarus IncSun PharmaSun Pharmaceutical Industriestype-2 diabetesUSUS market
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X